AeroShot Delivers the Taste of Chocolate Without the Calories
AeroShot Delivers the Taste of Chocolate Without the Calories
AeroDesigns, Inc. announces the U.S. launch of its zero-calorie, aerodynamic chocolate product invented by Harvard professor David Edwards
LS9 Announces Florida Plant Grand Opening and Receives $4.5 million from Florida Opportunity Fund
LS9 Announces Florida Plant Grand Opening and Receives $4.5 million from Florida Opportunity Fund
South san francisco, CA (May 14, 2012) – LS9, Inc., a technology leader in the development of renewable and sustainable products, today announced an investment from the Florida Opportunity Fund's (FOF) Clean Energy Investment Program, and the Grand Opening plans for its facility in Okeechobee, Florida.
Helicos BioSciences Corporation Settles its Patent Litigation Against Pacific Biosciences, Inc.
Helicos BioSciences Corporation Settles its Patent Litigation Against Pacific Biosciences, Inc.
Litigation Against Illumina, Life Technologies Continues
Affinnova Announces Record Sales
Affinnova Announces Record Sales
WALTHAM, Mass., May 17, 2012 (BUSINESS WIRE) -- Affinnova, Inc., the global leader in innovation software and services, has announced record sales for the prior twelve months ending March, 2012. Total sales increased 43% compared to the previous 12-month period. Non-U.S. sales rose to 18% of the business overall, as Affinnova has aggressively expanded its operations in Europe, hiring staff in the United Kingdom, France and Germany.
BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Mayo Medical Laboratories
BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Mayo Medical Laboratories
BG Medicine Announces Publication of First Study on Use of Galectin-3 inSelection of Drug Therapy in Heart Failure
BG Medicine Announces Publication of First Study on Use of Galectin-3 inSelection of Drug Therapy in Heart Failure
WALTHAM, Mass., May 14, 2012 (GlobeNewswire via COMTEX) -- BG Medicine, Inc.
Eleven Biotherapeutics Secures $20 Million and Expands Series A Financing
Eleven Biotherapeutics Secures $20 Million and Expands Series A Financing
Company to Advance its lead Drug Candidate, EBI-005, into Clinic Development for Dry Eye Disease
US Scientists Who Mean Business
Vaccine Could Stop Nicotine from Reaching the Brain
Vaccine Could Stop Nicotine from Reaching the Brain
The new antismoking technique uses nanoparticles to trigger an immune response.
By Conor Myhrvold
Seahorse Announces the XF Glycolysis Stress Test Kit
Seahorse Announces the XF Glycolysis Stress Test Kit
BILLERICA, Mass., April 25, 2012 -- /PRNewswire/ -- Seahorse Bioscience, the leader in cellular bioenergetic measurements, announced the launch of its newest stress test kit at the American Association of Cancer Research (AACR) Annual Meeting 2012. The XF Glycolysis Stress Test Kit is the first Standard for measuring glycolytic capacity in cells.

